As of 2025-10-22, the Intrinsic Value of Outlook Therapeutics Inc (OTLK) is -19.74 USD. This OTLK valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.41 USD, the upside of Outlook Therapeutics Inc is -1,499.79%.
Based on its market price of 1.41 USD and our intrinsic valuation, Outlook Therapeutics Inc (OTLK) is overvalued by 1,499.79%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -19.74 - -19.74 | -19.74 | -1,499.79% |
| DDM - Stable | (7.15) - (24.13) | (15.64) | -1209.5% |
| DDM - Multi | (11.35) - (30.47) | (16.62) | -1278.4% |
| Market Cap (mil) | 62.63 |
| Beta | 1.06 |
| Outstanding shares (mil) | 44.42 |
| Enterprise Value (mil) | 62.63 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.61% |
| Cost of Debt | 5.00% |
| WACC | 8.63% |